The stock carries a Zacks Rank #3 (Hold) currently. Boston Scientific’s Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal and ...

We recently compiled a list of the 12 Best Fundamental Stocks to Buy Now. In this article, we are going to take a look at ...

The company’s third-quarter earnings report for fiscal 2024 showed strong sales growth and adjusted per-share earnings of ...

Boston Scientific Corp. engages in the development ... The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral ...

Boston Scientific closes the year at historic highs ... includes diagnostic and invasive devices in the fields of Endoscopy, Cardiology, Electrophysiology, and Neuromodulation.

The company primarily operates through its MedSurg (endoscopy, urology ... there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this ...